Bariatric surgery in patients with interstitial lung disease
- PMID: 30367295
- DOI: 10.1007/s00464-018-6475-7
Bariatric surgery in patients with interstitial lung disease
Abstract
Background: Perioperative pulmonary complications are frequent in patients with interstitial lung diseases (ILD). Limited literature exists regarding the safety of bariatric procedures in patients with ILD. This study aims to assess the safety, feasibility, and outcomes of patients with ILD who underwent bariatric surgery at our institution.
Methods: After IRB approval, all patients with preoperative diagnosis of ILD who had bariatric surgery at an academic center between 2004 and 2014 were retrospectively reviewed.
Results: A total of 25 patients with ILD underwent bariatric surgery: Roux-en-Y gastric bypass (n = 17, 68%), sleeve gastrectomy (n = 7, 28%), and adjustable gastric banding (n = 1, 4%). Twenty-one patients (84%) were females. The median age and preoperative body mass index (BMI) were 53 (IQR 42-58) years and 39 (IQR 37-44) kg/m2, respectively. The median operative time and length of stay was 137 (IQR 110-187) min and 3 (IQR 2-5) days, respectively. The 30-day complications were reported in four patients (16%) but there was no pulmonary complication or unplanned admission to the intensive care unit. At 1-year follow-up (85%), the median BMI and excess weight loss were 30 (IQR 25-36) kg/m2 and 67% (IQR 45-100), respectively. Compared to preoperative values, there was significant improvement in the pulmonary function test (PFT) variables at 1 year with respect to forced vital capacity (62% vs 74%; n = 13, p = 0.003), and diffusing capacity of the lungs for carbon monoxide (53% vs 66%; n = 10, p = 0.003). Six out of the seven potential lung transplant candidates became eligible for transplantation after weight loss, and one of them had successful lung transplant at 88 months after bariatric surgery.
Conclusion: In our experience, bariatric patients with ILD achieved significant weight loss and improvement in PFT. Bariatric surgery in these higher risk ILD patients appears relatively safe with acceptable perioperative morbidity and improved candidacy for lung transplantation.
Keywords: Bariatric surgery; Interstitial lung disease; Obesity; Pulmonary disease; Weight loss.
Similar articles
-
Bariatric surgery in patients with pulmonary hypertension.Surg Obes Relat Dis. 2018 Oct;14(10):1581-1586. doi: 10.1016/j.soard.2018.07.015. Epub 2018 Jul 20. Surg Obes Relat Dis. 2018. PMID: 30449514
-
Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality.JAMA. 2018 Jan 16;319(3):279-290. doi: 10.1001/jama.2017.20513. JAMA. 2018. PMID: 29340677 Free PMC article.
-
Outcomes of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Patients Older than 60.Obes Surg. 2015 Dec;25(12):2251-6. doi: 10.1007/s11695-015-1712-9. Obes Surg. 2015. PMID: 26001882
-
Early Australian experience in robotic sleeve gastrectomy: a single site series.ANZ J Surg. 2017 May;87(5):385-389. doi: 10.1111/ans.13545. Epub 2016 Apr 15. ANZ J Surg. 2017. PMID: 27080457 Review.
-
Interstitial lung disease as an indication for pediatric lung transplant.Pediatr Pulmonol. 2024 Sep;59(9):2313-2320. doi: 10.1002/ppul.26812. Epub 2023 Dec 22. Pediatr Pulmonol. 2024. PMID: 38131509 Review.
Cited by
-
Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity.Int J Mol Sci. 2022 Jul 1;23(13):7349. doi: 10.3390/ijms23137349. Int J Mol Sci. 2022. PMID: 35806353 Free PMC article. Review.
-
Synergistic Integration of Multimodal Metabolic and Bariatric Interventions Transforming Transplant Care.J Clin Med. 2025 Aug 11;14(16):5669. doi: 10.3390/jcm14165669. J Clin Med. 2025. PMID: 40869495 Free PMC article. Review.
-
Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts.Nat Commun. 2023 Mar 17;14(1):1489. doi: 10.1038/s41467-023-37193-6. Nat Commun. 2023. PMID: 36932145 Free PMC article.
-
Linking Adiposity to Interstitial Lung Disease: The Role of the Dysfunctional Adipocyte and Inflammation.Cells. 2023 Sep 5;12(18):2206. doi: 10.3390/cells12182206. Cells. 2023. PMID: 37759429 Free PMC article. Review.
-
Current Beliefs and Practices Regarding the Management of Obesity in Patients with Progressive Interstitial Lung Disease.Ann Am Thorac Soc. 2022 Apr 15;19(9):1602-5. doi: 10.1513/AnnalsATS.202201-019RL. Online ahead of print. Ann Am Thorac Soc. 2022. PMID: 35427212 Free PMC article. No abstract available.
References
-
- Zammit C, Liddicoat H, Moonsie I, Makker H (2010) Obesity and respiratory diseases. Int J Gen Med 3:335–343. https://doi.org/10.2147/IJGM.S11926 - DOI - PubMed - PMC
-
- Pouwels S, Smeenk FWJM, Manschot L et al (2016) Perioperative respiratory care in obese patients undergoing bariatric surgery: implications for clinical practice. Respir Med 117(2016):73–80. https://doi.org/10.1016/j.rmed.2016.06.004 - DOI - PubMed
-
- Gupta PK, Gupta H, Kaushik M et al (2012) Predictors of pulmonary complications after bariatric surgery. Surg Obes Relat Dis 8(5):574–581. https://doi.org/10.1016/j.soard.2011.04.227 - DOI - PubMed
-
- Wallis A, Spinks K (2015) The diagnosis and management of interstitial lung diseases. BMJ 350:h2072. https://doi.org/10.1136/bmj.h2072 - DOI - PubMed
-
- Choi SM, Lee J, Park YS et al (2014) Postoperative pulmonary complications after surgery in patients with interstitial lung disease. Respiration 87:287–293. https://doi.org/10.1159/000357046 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials